Peapack Gladstone Financial Corp Astrazeneca PLC Transaction History
Peapack Gladstone Financial Corp
- $6.94 Billion
- Q3 2024
A detailed history of Peapack Gladstone Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 149,605 shares of AZN stock, worth $9.92 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
149,605
Previous 126,446
18.32%
Holding current value
$9.92 Million
Previous $9.86 Million
18.19%
% of portfolio
0.17%
Previous 0.15%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.17 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.78 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $205B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...